Sign in

You're signed outSign in or to get full access.

AS

American Strategic Investment Co. (NYC)·Q2 2025 Earnings Summary

Executive Summary

  • Q2 2025 revenue was $12.22M, down from $15.75M in Q2 2024 on the prior-year sale of 9 Times Square; GAAP net loss narrowed to $41.7M vs. $91.9M YoY given a smaller impairment charge this quarter .
  • Adjusted EBITDA fell to $0.38M (vs. $4.48M in Q2 2024) and Cash NOI declined to $4.20M (vs. $7.42M), reflecting lower rent base and elevated property-level costs; occupancy was flat at 82% QoQ while WALT extended to 6.0 years on two renewals .
  • Balance sheet metrics deteriorated: net debt rose to $344.7M with net debt/gross asset value at 63.6%, and weighted-average interest rate increased to 6.4% (from 4.4% in Q1) .
  • Notable events: lender commenced foreclosure proceedings on 1140 Avenue of the Americas (disclosed on the call), and post-quarter the NYSE notified the company of non-compliance with listing standards (30-day avg. market cap ~$34.3M; equity ~$35.5M as of 6/30/25), raising headline risk and strategic urgency .

What Went Well and What Went Wrong

What Went Well

  • Lease renewals at 123 William and 1140 Avenue of the Americas extended WALT to 6.0 years; management emphasized focus on tenant retention and lease extensions to stabilize the portfolio .
  • CEO reiterated strategy to divest select Manhattan assets (123 William, 196 Orchard) to retire debt and reinvest in higher-yield assets; management framed this as a key value-unlock lever .
  • Top-10 tenant credit mix remains anchored by investment-grade or implied investment-grade counterparties (77% of top-10 straight-line rent), supporting rent durability perceptions .

What Went Wrong

  • Revenue and cash generation compressed: revenue down to $12.22M and Cash NOI to $4.20M, driven by the reduced rent base following asset sales and higher interest burden, pressuring Adjusted EBITDA to $0.38M .
  • Material non-cash impairment ($30.56M) weighed on results; while lower than Q2 2024, it continues to signal valuation pressure in the portfolio .
  • Credit/liquidity risk elevated: foreclosure proceedings initiated at 1140 Avenue of the Americas, net debt/gross asset value rose to 63.6%, and the weighted-average interest rate stepped up to 6.4% from 4.4% in Q1 .

Financial Results

MetricQ4 2024Q1 2025Q2 2025
Revenue ($USD)$14.889M $12.308M $12.222M
Net Loss ($USD)$(6.650)M $(8.592)M $(41.660)M
Net Loss per Share ($)$(2.60) $(3.39) $(16.39)
EBITDA ($USD)$1.243M $(0.918)M $(30.265)M
Adjusted EBITDA ($USD)$1.252M $(0.832)M $0.381M
Cash NOI ($USD)$6.395M $4.234M $4.196M
Occupancy (%)80.8% 82.0% 82.0%
WALT (years)6.3 5.4 6.0
Weighted-Avg Interest Rate (%)4.4% 4.4% 6.4%
Net Debt ($USD)$340.2M $342.9M $344.7M
Estimates vs. ActualsQ2 2025
Revenue ConsensusNo published consensus*
EPS ConsensusNo published consensus*

Values retrieved from S&P Global.*

Segment/Portfolio Mix (Q2 2025 Annualized Straight-Line Rent)

Property TypeSL Rent ($USD)% SL RentSquare Feet (000s)% Sq Ft
Office$32.061M 71% 626 77%
Retail$12.133M 27% 159 20%
Other$0.886M 2% 24 3%
Total$45.080M 100% 809 100%

KPIs Snapshot

KPIQ4 2024Q1 2025Q2 2025
Properties (#)6 6 6
Tenants (#)56 83 83
Cash & Cash Equivalents ($USD)$9.8M $7.1M $5.3M
Net Debt / GAV (%)56.9% 57.9% 63.6%
Cash Paid for Interest (Quarter)$4.286M $4.593M $7.774M

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Financial guidance (Revenue, EPS, Adj. EBITDA)FY/Q3None issued None issued Maintained (no formal guidance)
Asset sales (123 William, 196 Orchard)2025“Marketing ongoing” “Continuing to market” Maintained process
Leverage/Capital allocation2025Use proceeds to retire debt, reinvest in higher-yield assets Same framework reiterated Maintained
Listing status2025CompliantReceived NYSE non-compliance notice 8/26/25 (post-Q2) New risk disclosed post-Q2

No quantitative revenue/EPS/NOI guidance was provided.

Earnings Call Themes & Trends

TopicQ4 2024 (Prev-2)Q1 2025 (Prev-1)Q2 2025 (Current)Trend
Asset sales/diversificationSold 9 Times Square; re-launched marketing for 123 William & 196 Orchard Actively marketing 123 William & 196 Orchard; plan to retire debt and buy higher-yield assets Continuing to market both assets for sale; proceeds to reduce debt and reinvest Steady execution emphasis
Leasing/occupancy80.8% occupancy; 6.3-year WALT Occupancy +120 bps QoQ to 82.0%; WALT 5.4 years Occupancy flat at 82.0%; WALT extended to 6.0 years via renewals Stabilizing with modest term extension
Balance sheetNet leverage 56.9%; all fixed-rate; 4.4% W.A. rate Net debt ~58%; 4.4% W.A. rate; 2.3-year W.A. maturity Net debt $344.7M; W.A. rate 6.4%; 1.8-year W.A. maturity Higher rate, shorter tenor
Credit/liquidity risksForeclosure proceedings commenced at 1140 Ave. of the Americas (lender) Deteriorating at asset-level
Listing compliancePost-Q2 NYSE notice: mkt cap and equity below $50M thresholds; plan due in 45 days Increased headline risk

Management Commentary

  • “We remain focused on operating and creating value at our current assets, with a focus on tenant retention… [and] opportunistically divest certain of our Manhattan assets and recycle the proceeds into higher-yielding assets to enhance our long-term portfolio value.” — CEO Nicholas Schorsch, Jr. .
  • “Second quarter revenue was $12.2 million… GAAP net loss… $41.7 million… Adjusted EBITDA was $0.4 million… Cash net operating income was $4.2 million…” — CFO Michael LeSanto .
  • “During the second quarter, the lender for 1140 Avenue Of The Americas commenced foreclosure proceedings with respect to the property.” — CFO Michael LeSanto .
  • “Our ongoing sale process… is designed to unlock substantial capital while reducing our debt burden… [and] reinvest in higher yielding assets to enhance our long term portfolio value.” — CEO Nicholas Schorsch, Jr. .

Q&A Highlights

  • The call featured prepared remarks; management disclosed the commencement of foreclosure proceedings at 1140 Avenue of the Americas and reiterated the asset sale strategy for 123 William and 196 Orchard .
  • No formal quantitative guidance was provided; management emphasized deleveraging and portfolio repositioning as priorities .

Estimates Context

  • Wall Street consensus from S&P Global was not available for Q2 2025 EPS or revenue (no published consensus), so no beat/miss determination can be made at this time.*
  • Given the lack of coverage, estimates may need to be initiated or re-established if/when the company completes asset sales and clarifies its go-forward earnings power.*

Values retrieved from S&P Global.*

Key Takeaways for Investors

  • Operating base is stable but smaller: recurring rent base post-asset sales is supporting ~82% occupancy; however, Cash NOI and Adjusted EBITDA remain under pressure at current scale .
  • Balance sheet risk rising: weighted-average interest rate climbed to 6.4% and cash paid for interest rose to $7.77M in Q2, reducing coverage and financial flexibility .
  • Asset-level stress is visible: lender initiated foreclosure at 1140 Avenue of the Americas; asset sale execution and timing are critical to de-risk .
  • Strategic pivot remains the catalyst: successful sales of 123 William and 196 Orchard could reduce leverage and fund higher-yield assets, potentially improving NOI durability and returns .
  • Listing risk adds urgency: NYSE non-compliance notice (post-Q2) increases headline volatility and the need to demonstrate a credible plan within prescribed timelines .
  • Near-term trading lens: headline sensitivity to updates on foreclosure, asset sale milestones, and the NYSE plan may dominate; absence of consensus estimates reduces traditional “beat/miss” catalysts .
  • Medium-term thesis: Execution on deleveraging and portfolio rotation, plus leasing to extend term and lift occupancy, are the key drivers for restoring earnings power and equity value .

Additional Data and References:

  • Q2 2025 8-K release and supplemental: financials, non-GAAP reconciliations, portfolio metrics .
  • Q2 2025 earnings call transcript: strategy, leasing, foreclosure disclosure .
  • Prior quarters for trend context: Q1 2025 8-K and supplement ; Q4 2024 8-K and supplement .
  • Other relevant release: NYSE continued listing notice (post-Q2) .